Skip to main content

EASD: Low-Dose Aspirin Tied to Lower Risk for New Diabetes in Older Adults

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

TUESDAY, Sept. 5, 2023 -- Aspirin treatment reduces the risk for incident diabetes in older adults, according to a study to be presented at the annual meeting of the European Association for the Study of Diabetes, held from Oct. 2 to 6 in Hamburg, Germany.

Sophia Zoungas, Ph.D., from Monash University in Melbourne, Australia, and colleagues investigated the treatment effect of low-dose aspirin on incident diabetes and fasting plasma glucose (FPG) levels among adults aged 65 years. and older. The participants (16,209 adults) were randomly assigned (1:1) to 100 mg daily enteric-coated aspirin or placebo.

The researchers found that during a median follow-up of 4.7 years, incident diabetes cases were identified in 459 participants in the aspirin group and 536 in the placebo group. The aspirin group had a lower risk for incident diabetes (hazard ratio, 0.85; P = 0.01) and a slower rate of increase in FPG (difference in annual FPG change, −0.006 mmol/L; P = 0.004).

“Given the increasing prevalence of type 2 diabetes among older adults, the potential for anti-inflammatory agents like aspirin to prevent type 2 diabetes or improve glucose levels needs further study,” the authors write.

Abstract

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Diabetes Increases Risk for Functional Limitations in Older Adults

FRIDAY, May 3, 2024 -- Older adults with diabetes are more likely to develop functional limitations than adults without diabetes, according to a study published online April 16 in...

SGLT2 Inhibitors Improve Outcomes in Patients With Diabetes Plus Kidney Disease

THURSDAY, May 2, 2024 -- Use of sodium–glucose cotransporter-2 inhibitors (SGLT2is) is associated with a substantially lower risk for dialysis and cardiovascular disease in...

American College of Physicians, April 18-20

The annual meeting of the American College of Physicians (Internal Medicine Meeting) was held from April 18 to 20 in Boston and was attended by internists, adult medicine...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.